Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company's CEO, Nadav Kidron will present at FireRock Capital's Micro-Cap Conference. Presentation Details: FireRock Capital' s Annual Micro-Cap Conference Date: Tuesday, October 28, 2014 Time: 9:15a
Vikramaditya Yadav of the Department of Chemical and Biological Engineering at the University of British Columbia to develop a targeted drug delivery system. Sazzad Hossain states, "We believe the development of this delivery system will position InMed to increase efficacies of our therapies as well as open additional industry opportunities for...
The patent covers the Company's key IntelliGel supramolecular drug delivery technology platform, compositions for pharmaceutical, cosmetic and personal care applications, and methods of making such compositions. x0D;.
Data on Drug Delivery Systems Described by A.A. Rosenkranz et al. For more information on this research see: Use of intracellular transport processes for targeted drug delivery into a specified cellular compartment. Biochemistry- Moscow, 2014; 79: 928-946. Biochemistry- Moscow can be contacted at: Maik Nauka, Interperiodica, Springer, 233 Spring St
For more information on this research see: Ca2+- Dependent Intracellular Drug Delivery System Developed with "Raspberry-Type" Particles-on-a-Particle Comprising Mesoporous Silica Core and alpha-Synuclein-Coated Gold Nanoparticles. ACS Nano, 2014; 8 (9): 8887-8895. ACS Nano can be contacted at: Amer Chemical Soc, 1155 16 TH St, NW, Washington, DC 20
Findings from School of Pharmaceutical Science in Drug Delivery Systems Reported. Our news editors obtained a quote from the research from the School of Pharmaceutical Science, "Currently, cancer research is focused on improving cancer diagnosis and treatment methods nanotechnology, which involves the design, characterization, production, and...
For more information on this research see: Natural and synthetic biomaterials for controlled drug delivery. Archives of Pharmacal Research, 2014; 37: 60-8. Archives of Pharmacal Research can be contacted at: Springer, 233 Spring Street, New York, NY 10013, USA. Our news correspondents report that additional information may be obtained by contacting
By a News Reporter-Staff News Editor at Biotech Week Icon Bioscience, Inc., a specialty biopharmaceutical company focused on utilizing its Verisome drug-delivery platform to develop unique intraocular eye-care therapeutics, announced that the last patient has completed treatment in its pivotal Phase 3 study of IBI-10090. "Thus, the superior d
New Drug Delivery Systems Study Findings Have Been Reported by Researchers at National Center for Nanoscience and Technology of China. Our news editors obtained a quote from the research from the National Center for Nanoscience and Technology of China, "Given the central role of platinum drugs in the clinic, it is critical to overcome cisplatin res
New Findings from Institute of Materials Research and Engineering in the Area of Drug Delivery Systems Reported. According to news reporting originating in Singapore, Singapore, by NewsRx journalists, research stated, "A drug delivery system based on poly grafted conjugated polyelectrolyte has been developed to serve as a polymeric photosensitizer
New Findings from Medical University in the Area of Drug Delivery Systems Reported. According to news reporting originating from Katowice, Poland, by NewsRx correspondents, research stated, "The blood-brain barrier significantly impedes treatment of central nervous system disorders by preventing drug entry into the brain. Our news editors obtained
New Findings in Drug Delivery Systems Described from Pusan National University. According to news originating from Busan, South Korea, by NewsRx correspondents, research stated, "Even though various multi-layered tablets have been developed for sustained release formulations, evaluations of mechanical properties during dissolution with drug release
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today reported positive top-line clinical results from its Phase IIa clinical trial of ORMD-0801, the company's proprietary oral insulin capsules, to treat type 1 diabetes. The trial was conducted in the United States under
By a News Reporter-Staff News Editor at Biotech Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventors Dudley, Robert E.; Constantinides, Panayiotis P., filed on June 12, 2014, was made available online on October 9, 2014. No assignee for this patent application has been ma
By a News Reporter-Staff News Editor at Biotech Week PARI Pharma GmbH has been issued patent number 8852557, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventors are Keller, Manfred; Schuschnig, Uwe; Zimmermann, Johann; Luber, Martin; Bohm, Andreas. This patent was filed on August 29, 2008
By a News Reporter-Staff News Editor at Biotech Week According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventors Houze, David; Hantman, Samara, filed on September 14, 2012, was published online on October 7, 2014. The assignee for this patent, patent number 8852628, is Noven Pharmaceuticals,
By a News Reporter-Staff News Editor at Biotech Week West Pharmaceutical Services, Inc. and HealthPrize Technologies, LLC announced a strategic collaboration to integrate HealthPrize's Software-as-a-Service medication adherence and patient engagement platform with West's injectable drug delivery systems, to provide an end-to-end connected...
By a News Reporter-Staff News Editor at Life Science Weekly Investigators discuss new findings in Proteomics. According to news originating from Hangzhou, People's Republic of China, by NewsRx correspondents, research stated, "Nowadays, a real challenge in cancer therapy is to design drug delivery systems that can achieve high concentrations of d
Persistence Market Research is released new forthcoming report on title "RNA Interference Drug Delivery Market: Global Industry Analysis and Forecast to 2020". However, aptamer drug delivery technology is the fastest growing sub-segment in global RNAi drug delivery market. Therapeutic segment includes infectious diseases, cardiology, oncology,...